Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ANIP | US
0.62
1.02%
Healthcare
Biotechnology
31/03/2024
05/07/2024
61.44
60.96
61.57
60.56
ANI Pharmaceuticals Inc. a biopharmaceutical company develops manufactures and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances oncology products hormones and steroids injectables and other formulations including extended release and combination products. The company manufactures oral solid dose products; semi-solids liquids and topicals; and potent products as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains wholesalers distributors and mail order pharmacies and group purchasing organizations. ANI Pharmaceuticals Inc. was incorporated in 2001 and is headquartered in Baudette Minnesota.
View LessStrong Revenue Growth (> 10%)
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
49.8%1 month
41.8%3 months
30.4%6 months
32.4%39.55
14.73
3.24
0.69
0.34
14.00
3.07
1.06
112.38M
1.29B
1.29B
-
10.96
1.38K
28.70
8.71
2.51
2.33
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
7.47
Range1M
10.66
Range3M
11.57
Rel. volume
0.65
Price X volume
7.95M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
MannKind Corporation | MNKD | Biotechnology | 5.13 | 1.40B | 1.99% | 130.50 | -162.73% |
Bicycle Therapeutics Limited | BCYC | Biotechnology | 20.21 | 1.39B | 3.22% | n/a | 12.31% |
Kiniksa Pharmaceuticals Ltd | KNSA | Biotechnology | 19.36 | 1.37B | 1.36% | 143.62 | 2.81% |
Longboard Pharmaceuticals Inc. Common Stock | LBPH | Biotechnology | 34.87 | 1.36B | 9.28% | n/a | 1.27% |
Belite Bio Inc | BLTE | Biotechnology | 45.5 | 1.36B | -0.55% | n/a | 0.00% |
BioCryst Pharmaceuticals Inc | BCRX | Biotechnology | 6.52 | 1.35B | 1.72% | n/a | -173.65% |
Verona Pharma plc | VRNA | Biotechnology | 16.11 | 1.31B | 2.55% | n/a | 22.79% |
Arcus Biosciences Inc | RCUS | Biotechnology | 14.12 | 1.28B | -1.67% | n/a | 1.56% |
Ardelyx Inc | ARDX | Biotechnology | 5.29 | 1.24B | -0.56% | n/a | 69.54% |
ARCUTIS BIOTHERAPEUTICS INC. | ARQT | Biotechnology | 10.49 | 1.21B | 9.27% | n/a | 91.91% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 13.45 | 1.31B | -0.37% | n/a | 20.15% |
REV Group Inc | REVG | Recreational Vehicles | 24.74 | 1.28B | -2.06% | 5.86 | 66.74% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.36 | 1.14B | 1.60% | n/a | -628.58% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 17.73 | 799.13M | -2.42% | n/a | 4070.84% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 32.65 | 667.35M | -2.74% | n/a | 4.21% |
Ennis Inc | EBF | Building Products & Equipment | 21.25 | 552.16M | -0.75% | 13.68 | 1.15% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 4.48 | 428.47M | -2.40% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 25.77 | 412.92M | -1.68% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.74 | 369.15M | -2.49% | 14.12 | 86.68% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.36 | 324.63M | -2.40% | 10.10 | 0.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 14.00 | -2.43 | Expensive |
Ent. to Revenue | 3.07 | 4,101.76 | Cheaper |
PE Ratio | 39.55 | 41.26 | Par |
Price to Book | 3.24 | 22.34 | Cheaper |
Dividend Yield | - | 2.39 | - |
Std. Deviation (3M) | 30.38 | 76.52 | Lower Risk |
Debt to Equity | 0.69 | 0.51 | Expensive |
Debt to Assets | 0.34 | 0.24 | Expensive |
Market Cap | 1.29B | 3.77B | Emerging |